Solid Tumor
📧 Sign up to get email alerts when something new happens for Solid Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-06-12Clinical Trial Update: Study to Assess Safety and Efficacy of the Second Mitochondrial-derived Activator of Caspases (SMAC) Mimetic Debio 1143 [Phase 1, Phase 2]
A study evaluating the safety and efficacy of Debio 1143, a SMAC mimetic, in solid tumors has completed Phase 1/2 with results posted.
-
CLINICAL_TRIALS trial_result · 2023-06-12Clinical Trial Update: Effect of Refnot on Immunity in Cancer Patients [Phase 2]
Phase 2 clinical trial update evaluating Refnot on immunity in cancer patients with solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2023-06-06Clinical Trial Update: BPB-101 in Subjects With Metastatic or Locally Advanced Solid Tumors [Phase 1, Phase 2]
Clinical trial update for BPB-101 in subjects with solid tumors (Phase 1/Phase 2); status currently UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2023-06-02Clinical Trial Update: A Study of SHR-1802 in Combination With Adebrelimab in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
A phase 1/2 study evaluating SHR-1802 in combination with adebrelimab in patients with advanced solid tumors.
-
CLINICAL_TRIALS trial_result · 2023-06-01Clinical Trial Update: Phase Ⅰ/Ⅱ Study of the HS-10365 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
Phase I/II study of HS-10365 in patients with advanced solid tumors is reported as an early clinical trial update with unknown status.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-04-27Clinical Trial Update: Safety and Efficacy of IMM01 Plus Tislelizumab in Patients With Advanced Solid Tumors and Lymphomas [Phase 1, Phase 2]
Phase 1/2 trial evaluating IMM01 in combination with tislelizumab for advanced solid tumors and Classic Hodgkin lymphoma is ongoing with unk…
-
CLINICAL_TRIALS trial_result · 2023-04-12Clinical Trial Update: Gut Microbial Metabolites Inosine Combined With PD-1/PD-L1 Inhibitor for Patients With Malignant Advanced Solid Tumors [Phase 2, Phase 3]
Phase 2/3 trial update evaluating inosine (gut microbial metabolite) in combination with PD-1/PD-L1 inhibitors for patients with advanced so…
-
CLINICAL_TRIALS trial_result · 2023-04-10Clinical Trial Update: IMM2902 in Patients With Advanced Solid Tumors Expressing HER2 [Phase 1, Phase 2]
Phase 1/2 trial update for IMM2902 in patients with HER2-expressing advanced solid tumors including advanced solid tumors, advanced lung can…
-
CLINICAL_TRIALS trial_result · 2023-03-31Clinical Trial Update: A Study of DB-1202 Monotherapy in Advanced Solid Tumors [Phase 1, Phase 2]
A clinical trial update for DB-1202 monotherapy in advanced solid tumors spanning Phase 1 and Phase 2; current status is UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2023-03-30Clinical Trial Update: Thymalfasin-based PRaG Mode for Advanced Refractory Solid Tumors [Phase 2]
Phase 2 clinical trial update for a thymalfasin-based PRaG mode in advanced refractory solid tumors.
-
CLINICAL_TRIALS trial_result · 2023-03-29Clinical Trial Update: PRECISE CURATE.AI Pilot Clinical Trial [Phase 1, Phase 2]
Pilot clinical trial update for PRECISE CURATE.AI in solid tumors (Phase 1/Phase 2) with unknown status.
-
CLINICAL_TRIALS trial_result · 2023-03-16Clinical Trial Update: First in Human Study of M4344 in Participants With Advanced Solid Tumors [Phase 1]
First-in-human Phase 1 trial of M4344 in participants with advanced solid tumors completed; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-03-16Clinical Trial Update: A Study of TFX05-01 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
Clinical trial update for TFX05-01 in patients with advanced solid tumors, spanning Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2023-03-03Clinical Trial Update: A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors [Phase 1, Phase 2]
A Phase I/II study investigating regorafenib in combination with avelumab in various solid tumors, spanning Phase 1 and Phase 2 cohorts.
-
CLINICAL_TRIALS trial_result · 2023-03-03Clinical Trial Update: Nivolumab and Pembrolizumab Dose Optimisation in Solid Tumours With CURATE.AI Platform and Sequential ctDNA Measurements [Phase 1, Phase 2]
Clinical trial update evaluating dose optimization of nivolumab and pembrolizumab in solid tumors using the CURATE.AI platform with sequenti…
-
CLINICAL_TRIALS trial_result · 2023-03-01Clinical Trial Update: A Study of RD14-01 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1/2 study of RD14-01 in patients with advanced solid tumors is ongoing; current status is UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: A First-in-Human Study of CDK-002 (exoSTING) in Subjects With Advanced/Metastatic, Recurrent, Injectable Solid Tumors [Phase 1, Phase 2]
First-in-human study of CDK-002 (exoSTING) in advanced/metastatic, recurrent injectable solid tumors completed phases 1 and 2.
-
CLINICAL_TRIALS trial_result · 2023-01-06Clinical Trial Update: Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101) [Phase 1, Phase 2]
Open-label, dose-escalation study of pemigatinib in advanced malignancies (FIGHT-101) completed; results posted.
-
CLINICAL_TRIALS trial_result · 2023-01-04Clinical Trial Update: A Clinical Trial of ICP-192 in Treated Patients With Advanced Solid Tumors With FGF/FGFR Gene Alterations [Phase 2]
A Phase 2 clinical trial update evaluating ICP-192 in treated patients with advanced solid tumors possessing FGF/FGFR alterations is ongoing…
-
CLINICAL_TRIALS trial_result · 2022-12-13Clinical Trial Update: The Phase I/Phase II Clinical Study of VC004 in Patients With Localized Advanced/Metastatic Solid Tumors [Phase 1, Phase 2]
Phase I/II clinical trial update for VC004 in localized advanced/metastatic solid tumors; status not disclosed.
-
CLINICAL_TRIALS trial_result · 2022-12-09Clinical Trial Update: Clinical Trial of TQB2618 Injection Combined With TQB2450 Injection in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
Clinical trial update for TQB2618 and TQB2450 in advanced solid tumors (Phase 1/Phase 2).
-
CLINICAL_TRIALS trial_result · 2022-12-02Clinical Trial Update: A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers [Phase 1, Phase 2]
Phase 1/2 trial evaluating tremelimumab and IV durvalumab with Poly-ICLC in biopsy-accessible cancers; completed with results posted in 2022…
-
CLINICAL_TRIALS trial_result · 2022-11-25Clinical Trial Update: Study to Evaluate the Efficacy/Safety of IPI-549 in Combination With Nivolumab in Patients With Advanced Urothelial Carcinoma (MARIO-275) [Phase 2]
Phase 2 trial evaluating IPI-549 in combination with nivolumab for advanced urothelial carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2022-11-02Clinical Trial Update: A Study of T3011 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
A clinical trial update for T3011 administered intratumorally in advanced solid tumors, including phase 1 and phase 2 cohorts.
-
CLINICAL_TRIALS trial_result · 2022-11-02Clinical Trial Update: A Feasibility Study for the Use of Multispectral Optoacoustic Tomography in the Detection of Tumors [NA]
Feasibility study evaluating multispectral optoacoustic tomography for detecting solid tumors; completed with results posted in 2022.